Insiders Tarsus Pharmaceuticals, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 11:39:19 2024-05-20 EDT			5-day change	1st Jan Change
38.88 ^USD	+1.67%		+0.76%	+90.91%

05-15	Transcript : Tarsus Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 01:55 PM
05-09	Oppenheimer Adjusts Tarsus Pharmaceuticals Price Target to $61 From $59, Maintains Outperform Rating	MT

Tarsus Pharmaceuticals, Inc. Announces Executive Changes	01-18	CI
Tarsus Pharmaceuticals Insider Sold Shares Worth $810,623, According to a Recent SEC Filing	12-22	MT
Tarsus Pharmaceuticals Insider Sold Shares Worth $136,286, According to a Recent SEC Filing	12-01	MT
Tarsus Pharmaceuticals Insider Sold Shares Worth $136,270, According to a Recent SEC Filing	12-01	MT
Tarsus Pharmaceuticals Insider Sold Shares Worth $146,933, According to a Recent SEC Filing	11-17	MT
Tarsus Pharmaceuticals Insider Sold Shares Worth $105,920, According to a Recent SEC Filing	23-10-20	MT
Tarsus Pharmaceuticals Insider Sold Shares Worth $137,680, According to a Recent SEC Filing	23-09-22	MT
Insider Sell: Tarsus Pharmaceuticals	23-08-25	MT
Insider Sell: Tarsus Pharmaceuticals	23-07-21	MT
Insider Sell: Tarsus Pharmaceuticals	23-07-14	MT
Insider Sell: Tarsus Pharmaceuticals	23-06-16	MT
Insider Sell: Tarsus Pharmaceuticals	23-05-12	MT
Insider Sell: Tarsus Pharmaceuticals	23-05-03	MT
Tarsus Pharmaceuticals, Inc. Appoints Jeff Farrow as Chief Strategy Officer	23-04-24	CI
Tarsus Pharmaceuticals Names Jeff Farrow as Chief Financial Officer	23-04-24	MT
Insider Sell: Tarsus Pharmaceuticals	23-04-21	MT
Insider Sell: Tarsus Pharmaceuticals	23-02-13	MT
Tarsus Pharmaceuticals, Inc. Announces Board Changes	22-12-07	CI
Insider Sell: Tarsus Pharmaceuticals	22-11-17	MT
Insider Sell: Tarsus Pharmaceuticals	22-11-14	MT

No results for this search